Previous Close | 0.5558 |
Open | 0.5535 |
Bid | 0.5234 x 400 |
Ask | 0.5316 x 300 |
Day's Range | 0.5201 - 0.5598 |
52 Week Range | 0.2900 - 1.6700 |
Volume | |
Avg. Volume | 2,383,311 |
Market Cap | 109.247M |
Beta (5Y Monthly) | 1.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.50 |
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RICHMOND, Calif., May 02, 2024--Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT